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A B S T R A C T
As optoacoustic tomography (OT) emerges as a mainstream pre-clinical imaging modality, understanding the
relationship between optoacoustic and other imaging biomarkers in the context of the underlying tissue biology
becomes vitally important. Complementary insight into tumour vasculature and hypoxia can be gained using OT
alongside magnetic resonance imaging (MRI)-based techniques. To evaluate the relationship between these
metrics and the relative performance of the two modalities in assessment of tumour physiology, co-registration
of their output imaging data is required. Unfortunately, this poses a signiﬁcant challenge due to diﬀerences in
animal positioning during imaging. Here, we present an integrated framework for registration of OT and MR
image data in mice. Our framework combines a novel MR animal holder, to improve animal positioning during
imaging, and a landmark-based software co-registration algorithm. We demonstrate that our protocol sig-
niﬁcantly improves registration of both body and tumour contours between these modalities, enabling more
precise multi-modal tumour characterisation.
1. Introduction
Optoacoustic tomography (OT) is an emerging imaging modality,
able to reveal the distribution of tissue optical absorption coeﬃcient in
real-time with a spatial resolution of ∼180 μm at ∼3 cm penetration
depth [1]. Thanks to the distinct optical absorption proﬁles of oxy- and
deoxyhaemoglobin, acquiring OT data at multiple wavelengths (mul-
tispectral optoacoustic tomography, MSOT) makes it possible to derive
optoacoustic imaging biomarkers of total haemoglobin concentration
(THb) and blood oxygenation (SO2) [2]. Application of these functional
MSOT imaging biomarkers has been shown to provide insight into both
the architecture and function of the blood vasculature, for example, in
cancer imaging, where it can be used to monitor tumour development
[3,4] and detect response to therapy [5,6].
Functional imaging of the blood vasculature is also possible with a
wide range of magnetic resonance imaging (MRI)-based techniques.
Taking the example of cancer imaging, dynamic contrast enhanced
(DCE) MRI [7], blood oxygen level dependent (BOLD) [8], oxygen
enhanced (OE) MRI [9] and arterial spin labelling (ASL) MRI [10] have
all been demonstrated to provide insight into tumour blood vessel
function and the surrounding tissue hypoxia.
MSOT-measured THb and SO2 biomarkers have been shown to in-
dicate tumour vascular maturity [4], while functional MR methods
provide complementary measures of vascular perfusion and perme-
ability [7]. Both approaches can also provide insight into tissue hy-
poxia. While MSOT lacks the outstanding anatomical soft tissue in-
formation and versatility of the multiple MRI contrast mechanisms, it
does provide whole body functional imaging in small animals at high
spatio-temporal resolution with a diverse range of opportunities for
molecular imaging using contrast agents [11]. Combining the strengths
of these complementary imaging modalities can therefore provide de-
tailed insight into the functional characteristics of tumour vascular
phenotypes as well as tissue hypoxia. Further, important translational
questions arise as to whether and if so how these complementary
imaging biomarkers relate and which provide the best sensitivity for in
vivo cancer imaging.
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The correct combination of spatial information from diﬀerent ima-
ging modalities requires careful alignment of the images and hence an
eﬃcient co-registration algorithm. This is usually achieved in both
patient and small-animal imaging by careful body positioning and
scanning process optimisation, aided by software-based alignment.
Well-established, clinically used solutions are available [12,13] and
provide excellent results for fusion of positron emission tomography
(PET), computed tomography (CT) and MRI data. Unfortunately,
modalities such as OT that involve diﬀerent positioning of the animal or
patient pose a signiﬁcant challenge to co-register. As MSOT typically
requires suspending the animal under water, the distribution of external
forces exerted on the animal are distinct from forces acting in con-
ventional imaging, leading to deformations that need to be corrected.
Successful co-registration of OT and MR images has been reported
previously in the brain of small animals [14,15], however, being con-
tained within the skull, the brain is not subject to any deformation due
to external forces, making it a relatively simple organ to co-register.
Here, we present a new integrated framework for registration of
MSOT and MR image data in pre-clinical studies of mice, which can be
applied to soft, deformable tissues such as tumours. The method com-
bines a novel animal holder design and a robust co-registration algo-
rithm. We ﬁrst describe the method and show its performance for co-
localization of the internal tumour structures between the modalities.
We then demonstrate the improvement in co-registration achieved by
the combination of hardware and software-based solutions, compared
to the manual overlay of the tumour regions with standard animal
holders used for MSOT and MRI. Finally, we demonstrate the applica-
tion of the co-registration framework for comparison of perfusion-based
data recorded using MSOT and MRI.
2. Methods
2.1. Animal experiments
All animal procedures were conducted in accordance with project
(70-8214) and personal license (IDCC385D3) issued under the United
Kingdom Animals (Scientiﬁc Procedures) Act, 1986 and were approved
locally under compliance form number CFSB0671. Subcutaneous tu-
mours were established in male BALB/c nude mice (Charles River, 7–10
weeks old, 17–22 g) by inoculation of cells from one of three diﬀerent
cancer cell lines in both ﬂanks (1.5× 106 LNCaP prostate adenocarci-
noma cells, n= 3 mice; 1.5× 106 PC3 prostate adenocarcinoma cells,
n= 3 mice; 1× 106 mouse K8484 pancreatic adenocarcinoma cells,
n= 3 mice) in 100 μL phosphate buﬀered saline (PBS). Using three
diﬀerent cell lines allowed us to investigate the co-registration proce-
dure across a range of morphological and functional characteristics.
2.2. Multispectral optoacoustic tomography (MSOT)
An MSOT inVision 256-TF commercial small animal imaging system
(iThera Medical GmbH) was used. Brieﬂy, a tunable optical parametric
oscillator (OPO) pumped by an Nd:YAG laser provides excitation pulses
with a duration of 9 ns at wavelengths from 660 nm to 1200 nm at a
repetition rate of 10 Hz with a wavelength tuning time of 10ms and a
peak pulse energy of 90mJ at 720 nm. Ten arms of a ﬁbre bundle
provide uniform illumination of a ring-shaped light strip of approxi-
mately 8mm width. For ultrasound detection, 256 toroidally focused
ultrasound transducers with a centre frequency of 5MHz (60% band-
width) are organized in a concave array of 270 degree angular coverage
and a radius of curvature of 4 cm.
Mice were prepared according to our standard operating procedure
[16]. Each mouse was anaesthetised using<3% isoﬂurane and moved
into a custom animal holder (iThera Medical GmbH), wrapped in a thin
polyethylene membrane, with ultrasound gel (Aquasonic Clear, Parker
Labs) used to couple the skin to the membrane. The holder was then
placed within the MSOT system and immersed in degassed water
maintained at 36 °C. The mouse was allowed to stabilise for 15min
within the system prior to initialisation of the scan and its respiratory
rate was then maintained in the range 70–80 bpm with ∼1.8% iso-
ﬂurane concentration for the entire scan. The imaging slice was chosen
to show largest cross-sectional area of the tumours on one or both ﬂanks
where possible. The position of the slice relative to the tumor edges was
noted. Images were acquired in the single slice using 10 wavelengths
between 700 nm and 880 nm and averaging of signals from 6 pulses per
wavelength; a single slice acquisition was 5.5 s in duration. For Oxygen
Enhanced Optoacoustic Tomography, 70 such images were acquired
continuously, with the breathing gas switched from medical air (21%
Oxygen) to pure oxygen (100% Oxygen) after 30 scans, for the purpose
of quantiﬁcation of the response in blood oxygen saturation to such
deﬁned oxygen challenge.
2.3. Magnetic resonance imaging (MRI)
A 9.4 T Agilent MRI system (Agilent, Santa Clara, USA) running
VnmrJ 3.1, using an Agilent quadrature transmit/receive millipede
volume coil of 38mm inner diameter was used. The same anaesthesia
protocol as for optoacoustic imaging experiments was maintained. A
physiological monitoring system was used for observing mouse status
and for sequence triggering (SAII, Stony Brook, NY, USA). The core
temperature of the mouse was monitored using a rectal probe, and
stabilized to 37 °C using an air heating system. Firstly, coronal multi-
slice T2-weighted images were acquired covering the entire tumour
using a respiratory-gated fast spin-echo sequence (ﬁeld of view 40mm,
slice thickness/gap 0.95/0.05mm, ×256 256 points, TR 2000ms, echo
spacing 9ms, echo train length 8, eﬀective TE 36ms, 2 averages, 3–4
slices acquired per gate) with chemical-shift-selective fat suppression.
Based on these maps, axial imaging slices were chosen, such that centre
slice would best match the MSOT imaging slice based on the slice with
highest cross-sectional area and distances from tumor edges matching
these observed in MSOT. The axial T2 weighted images were then ac-
quired covering the entire tumour, using a fast echo sequence with
parameters as above.
Dynamic contrast enhanced (DCE)-MRI data were acquired using a
spoiled gradient echo sequence (ﬁeld of view 40mm, 2mm slice,
×128 128 points, TR 20ms, TE 1.62ms, 2 averages). 10 images were
acquired during the 1 minute prior to administration of contrast agent
(Gadavist, Bayer, 200 μmol/kg) to provide a baseline reference and 120
images were acquired in the 11min after injection.
2.4. Hardware for improved co-localization
To facilitate co-registration of MSOT and MRI data, a new mouse
holder was developed to reproduce the spatial positioning and body
deformation of the MSOT (Fig. 1a) during the MRI acquisition as ac-
curately as possible. This was achieved using a silicone bed (Fig. 2a) for
MRI imaging. The main objective of the design process was to closely
resemble the anatomical positioning in the MSOT device. The holder
was fabricated based on photogrammetry, a process which allowed for
a 3D model of the mouse suspended in PE ﬁlm to be produced based on
a set of pictures taken from diﬀerent angles. A point cloud is generated
from these images by aligning the camera positions with subsequent
conversion into a mesh, performed with the software 3DF Zephyr v3.5
(3DFLOW, Italy). Due to the low resolution of the mesh, the estimated
deformation was transferred to a 3D model (Fig. 2b) from the Digi-
mouse atlas [17] using the software Fusion 360 (Autodesk, US). The
resulting model was converted into a mold (by a adding a baseplate) in
STL ﬁle format, which is available on a GitHub repository together with
an additional model to accommodate diﬀerent tumour sizes. The result
was then printed with Polylactic acid (PLA) using an Anet A6 3D printer
(Anet, China), instructed with the slicer software Ultimaker Cura 2.6
(Ultimaker, Netherlands). The 3D printed mold was inserted into a
conventional MRI bed, with two circular disks as silicone leakage
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blocker, and the resulting cavity was ﬁlled with an equal mixture of A
and B component of the chosen silicone (Polycraft T15 Translucent
Silicone, MB Fibreglass) before being cured for 24 h. Extra soft silicone
(Shore Hardness A15) was used to increase compressibility in order to
accommodate subtle alterations in individual mouse anatomies. Sub-
sequently, the negative mold was removed, the silicone bed taken out
and the excess silicone trimmed with a blade. The full process is sum-
marised in a ﬂow chart in Fig. 2c.
After imaging in the MSOT, mice were maintained under anaes-
thesia and transferred for MRI. A subset of =n 4 mice (3 LNCaP tumour
bearing and 1 PC3 tumour bearing) underwent MRI placed in the prone
position in a half-pipe plastic holder, with the tumours on the back
facing upwards using the conventional MRI holder geometry (Fig. 1 b).
The remaining 5 animals (2 PC3 tumour bearing and 3 K8484 tu-
mour bearing) were scanned in the custom silicone holder (Fig. 2).
Transfer into the silicone MRI bed was made in a smooth motion while
maintaining the supine orientation of the mouse to preserve the posi-
tioning. The silicone bed showed a large, broad nuclear magnetic re-
sonance excitation at 7 ppm upﬁeld of water, which was clearly visible
in fast spin-echo images. Image registration was greatly simpliﬁed by
suppressing this signal, as the silicone is not present in the MSOT image
data. Therefore, for imaging sessions employing the silicone bed, a
modiﬁed chemical-shift selective fat suppression sequence was em-
ployed, using a sinc pulse of bandwidth 3 kHz centred at 2 kHz from the
water peak, between the fat and silicone resonances, to suppress both
fat and silicone.
2.5. Software co-registration
The main objective of any general co-registration software is to
merge the coordinate system of the moving image IM with the ﬁxed (or
reference) image IF. The transformation matrix T is used to warp the
moving image in order to minimise the error metric with the ﬁxed
image. This process is iterated until a certain convergence criterion is
reached.
A landmark-based co-registration approach [18] based on non-re-
ﬂective similarity with the addition of optional reﬂection was used to
register the tumour areas between modalities, utilising a set of promi-
nent anatomical features including the tumour edges and spine location
as landmarks. The positions of these features, identiﬁed manually, were
denoted in the MR image as IM and the matching positions in the MSOT
image as IF. These vectors were then used to calculate the transforma-
tion matrix and transform both modalities into the same coordinate
space, minimising the euclidean distance between the landmarks. A
landmark-based approach was chosen to maximise robustness. High
structural homogeneity of xenograft tumours and their regular shape
can limit the performance of other, internal information or shape based
[19] algorithms.
The registration procedure was implemented in two steps, each
constituting a landmark-based co-registration process. The ﬁrst step
ensured proper alignment between the body contours in MSOT and
MRI, which provides constrained initial conditions to the tumour
alignment, while the second step provided further alignment of the
Fig. 1. Conventional MSOT and MRI holder geometries. (a) Animal holder geometry and example image showing the total haemoglobin signal after spectral
unmixing, acquired using MSOT. (b) Conventional animal holder geometry and example fast spin-echo image from MRI.
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tumours. Landmarks for the ﬁrst step were the spine and characteristic
anatomical features visible in MRI and MSOT, such as contact points
between tumours and body (Fig. 3). Second step landmarks were de-
ﬁned by points along the outline of the tumour: up to two points on an
axis between the tumour and mouse body; and up to two points on the
perpendicular axis (Fig. 5). The corresponding similarity-based trans-
formation matrix was calculated using the MATLAB function ﬁtgeotrans.
2.6. Image and statistical analysis
All image analysis was performed in MATLAB 2016a (Mathworks)
using the Image Processing Toolbox, the Computer Vision Toolbox and
custom scripts unless otherwise stated. All image data and custom
analysis codes will be made openly available at doi: 10.17863/
CAM.39741.
Image reconstruction was performed using an acoustic back-
projection algorithm (iThera Medical GmbH) with an electrical impulse
response correction, to account for the frequency dependent sensitivity
proﬁle of the transducers. Images were reconstructed with a pixel size
of 100 μm× 100 μm which is approximately equal to half of the in-
plane resolution of the InVision 256-TF. It should be noted that the out-
of-plane resolution of this system is approximately 0.9 mm [20].
Pseudoinverse matrix inversion (pinv function in MATLAB 2016a) was
applied to the measured optoacoustic spectrum in each pixel to calcu-
late the relative oxy- [HbO2] and deoxy-haemoglobin [Hb] signal. The
presented images illustrate the total haemoglobin signal [ +HbO Hb2 ]
unless otherwise stated. Apparent blood oxygen saturation SO2MSOT was
calculated as a ratio of oxy- to total haemoglobin [4].
All MR images were ﬂipped horizontally prior to image registration.
The position of the slice analysed was chosen by the operator to best
match the location of the imaging slice in OT, acquired directly before
the MRI.
The analysis of registration accuracy of body and tumour contours
was performed by calculating the Dice Similarity Coeﬃcient (DSC).







| | | |
, which allows quantiﬁcation of the overlap between two binary masks,
X and Y (i.e. original MRI body/tumour mask and the mask obtained
from the MSOT image after co-registration). The higher the DSC, the
Fig. 2. Novel MRI holder geometry. (a) Design of the silicone holder to achieve a comparable anatomical cross-section within MRI and MSOT. (b) Rendering of the
silicone bed and the corresponding 3D printed mold. (c) Flowchart with individual steps for generation of the silicone bed (FDM=Fused Deposition Modeling).
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better the overlap between the two binary masks and therefore, the
more accurate the image registration result.
The results were compared on a per-tumour basis. Diﬀerences in
DSCs between conventional and novel holder geometries as well as
before and after landmark-based registrations (for body and tumour)
were statistically tested with two-tailed paired t-tests (in the case of
equal variances between sets of samples) and two-tailed unpaired t-tests
(in the case of unequal variances between sets of samples). Data are
reported as median± standard deviation, unless otherwise stated.
DCE-MRI signal area under the curve (AuC) 1min after contrast
administration was compared to the change in blood oxygen saturation
(SO2MSOT) as measured by Oxygen Enhanced Optoacoustic Tomography
in response to an oxygen challenge [4]. The tumour pixels were bi-
narised into ‘responding’ and ‘non-responding’. The pixels were classi-
ﬁed as responding when the diﬀerence between the average SO2MSOT
under air breathing and the last 20 frames (under oxygen breathing),
exceeded twice the standard deviation of the SO2MSOT under air
breathing (the ﬁrst 20 frames). The maps of such calculated response
was co-registered with the DCE MRI AuC maps. The median DCE AuC
values in the regions showing positive MSOT response and the rest of
the tumour area were compared.
3. Results
3.1. Novel holder geometry improves visual anatomical similarity between
MSOT and MRI
Visual inspection of MRI and MSOT images acquired with the con-
ventional and novel MRI holder geometries yielded distinct diﬀerences
in body shape and anatomical appearance (Fig. 3). Overall body shape
and relative tumour location were not easily comparable for tumours
imaged with the conventional protocol, while the new holder showed a
high degree of similarity in body contour and tumour locations. A
quantitative comparison of the contours of the mouse bodies in MSOT
and MRI images using Dice similarity coeﬃcients (DSCs) showed sig-
niﬁcant improvement ( =p 0.03, unpaired t-test) with the novel MRI
holder, resulting in a higher DSC (0.63± 0.05 vs. 0.52± 0.07, novel vs.
conventional). The higher DSC indicates that the novel MRI holder
more accurately represents the body deformation observed in the
MSOT.
3.2. Landmark-based contour registration improves animal body alignment
Landmark-based contour registration was then applied to MSOT and
MR images acquired using both the conventional and novel MRI holders
Fig. 3. Qualitative comparison of tomographic image data from OT and MRI modalities using the conventional and novel MRI holders. Top: MSOT/MRI image pair
with conventional holder geometry as in Fig. 1. Tumour R is not visible in the plane of the corresponding MR image. Bottom: MSOT/MRI image pair with novel holder
geometry as in Fig. 2.
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Fig. 4. Comparison of body contour overlays of MRI/MSOT image pairs for conventional and novel holder geometries. (a) Body contour pairs (derived from binarized
body outlines) for MSOT and MRI. Use of the novel protocol improves the agreement substantially (overlaid MSOT and MRI contours shown in blue and orange
respectively). (b) Quantitative comparison of Dice similarity coeﬃcient ( =n 4 for conventional holder and =n 5 for novel MRI holder). * <p 0.05, ** <p 0.01, ***
<p 0.001 by unpaired two-tailed t -test (unequal variances) and paired two-tailed t -test (equal variances).
Fig. 5. Overlays of tumour contours from MRI/MSOT image pairs before and after landmark-based optimization. (a) Comparison of a tumour outline before and after
landmark-based tumour registration. (b) Quantiﬁcation of the improvement in Dice similarity coeﬃcient ( =n 15 tumours, combined data for conventional and novel
MRI holder geometry). ** <p 0.01 by paired two-tailed t -test (equal variances).
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(illustrated in Fig. 4a). The diﬀerence between the conventional and
novel MRI holders was more signiﬁcant ( =p 0.002, unpaired t-test)
following landmark-based registration with further improved DSCs
(0.92± 0.02 vs. 0.83± 0.03, novel vs. conventional). In total (Fig. 4b),
the contour registration procedure improved DSCs for body contour
overlay signiﬁcantly, both for the conventional (ΔDSC=0.31,
=p 0.004, paired t-test) and novel (ΔDSC=0.29, p=7.2× −10 5,
paired t-test) holder. Comparing the performance of three operators
(one expert, two non-experts) resulted in very robust results post
transformation with DSC standard deviations ranging from 0.0057 to
0.0276, and an average standard deviation of 0.0157 by taking the
square root of the averaged variances.
3.3. Landmark-based tumour contour optimisation further improves local
anatomical similarity
Following the body contour registration, each tumour was in-
dividually co-registered as an additional optimisation step. The tumour
contours showed a qualitatively higher agreement after this additional
landmark-based optimisation. The gain in registration accuracy was
estimated to be between 5 and 15 pixels (375 μm–1125 μm), based on
the distances between the co-registered tumour outlines (Fig. 5a).
Quantitative assessment also showed in a signiﬁcant improvement in
tumour mask overlay DSCs ( =p 0.005, paired t-test) after landmark-
based transformation of tumour masks (pre-transform: 0.85± 0.06 vs.
post-transform: 0.92± 0.04, Fig. 5b). When comparing the performance
of three operators (one expert, two non-experts), we obtained con-
sistent results post transformation with strong robustness. This was
quantiﬁed by DSC standard deviations ranging from 0.0079 to 0.0409,
and an average standard deviation of 0.0257 by taking the square root
of the averaged variances.
3.4. Application of the co-registration framework for comparison of data
acquired using MSOT and MRI
Comparison of the anatomical similarity of the imaging data from
the two modalities subjected to our co-registration framework was
made in three K8484 tumour bearing mice. K8484 tumours were used
for this purpose as they contain heterogeneous structural features
visible in both MSOT and MRI. Upon visual inspection of images from
three mice bearing this tumour type, it can be seen that the body shapes
and tumour locations images demonstrate high anatomical similarity
(Fig. 6). The pattern contrast in the MSOT Total Haemoglobin (THb)
and MRI T2 weighted (T2w) images suggest these are necrotic areas of
diﬀerent characteristics. Haemorrhagic necrosis may produce high THb
and low T2w signal, while non-haemorrhagic necrosis is likely to show
the opposite due to the lack of haemoglobin in the area. Considering the
feature locations (deﬁned as distinct features in MRI and MSOT images
belonging to the same structure, denoted by red annotations in Fig. 6),
we established that the relative distance between the centroids of fea-
tures between modalities across three observers showed a close agree-
ment (ranging from 0.95 to 6.7 pixels, 71 μm to 503 μm, when com-
paring euclidean distances of feature centroids as estimated registration
error). The standard deviations of selected points and the resulting
euclidean distances between MRI and MSOT across all three observers
were 0.66, 0.41, and 2.03 pixels, for each tumour respectively. In Fig. 6,
the red rectangle indicates the extent of the observed features in MRI/
MSOT image pairs, whereas the red asterisk highlights the point se-
lected by the ﬁrst operator within the feature. This point was subse-
quently used for determining the relative distance between modalities.
A comparison of functional imaging data was then made in the same
K8484 tumours based on imaging data recorded using DCE-MRI and
Oxygen Enhanced OT (OE-OT) protocols, which have been previously
shown to relate to tumour perfusion and vascular function [6]. Visual
comparison of DCE-MRI and OE-OT images (Fig. 7a) shows a similar
distribution of perfused pixels in both modalities, with a greater
number in the rim compared to the core of the tumour, as is commonly
reported in subcutaneous xenografts. Quantitative comparison of DCE-
MRI enhancement in regions of OE-OT response (Fig. 7b) shows a
markedly stronger DCE-MRI enhancement in the areas showing positive
response in the OE-OT, suggesting a functional relationship between
these imaging biomarkers.
4. Discussion
Co-registration of images between modalities enables the combi-
nation of complementary information provided by diﬀerent imaging
methods. Due to deformation of the animal or patient between scans,
correct alignment of images can pose a signiﬁcant challenge and re-
quire both hardware and software-based optimisation approaches. In
this work, we describe an integrated hardware and software framework
for co-registration of mouse MSOT and MR imaging data. Without co-
registration, these modalities produce very diﬀerent images of the
sample, due to diﬀerent animal positioning and stress distribution.
On the hardware side, a novel silicone MRI animal holder was de-
veloped, which was designed to mimic the external stresses acting on
the mouse body in the MSOT. Introducing the new holder alone already
signiﬁcantly improved the similarity in the shape of the entire mouse
body contour as well as the individual tumour contour, contributing to
more accurate co-registration. Importantly, the use of the holder did not
increase animal preparation time or cause any side eﬀects for animal
welfare during imaging. Fabrication of the holder is simple and in-
expensive, as soft two-component silicone is poured over a 3D printed
mouse mold. The protocol oﬀers a simple solution to improve MSOT/
MR image co-registration.
A software tool for landmark-based image co-registration was then
established to further improve the co-registration and enable per-pixel
analysis of the combined multi-modal images. The transformation
matrix for the MSOT images was calculated to maximise similarity
between body and tumour outlines in both modalities as well as to
minimise the distances between anatomical landmarks. The result of
applying this software tool was a co-localisation error up to several
100 s of microns, comparable to the typical resolution of both mod-
alities. The robustness of the landmark-based co-registration approach
was veriﬁed by comparing the positioning of landmarks by several
operators, yielding a close agreement. This framework also enabled per-
pixel combination and comparison of the insight oﬀered by MSOT and
MRI in functional imaging. The relationship between tumour perfusion,
provided by early DCE-MRI enhancement [9], and vascular function,
given by the MSOT response to oxygen challenge [6], served as a proof
of concept for further MSOT/MRI comparison. In the future, other al-
gorithms introducing corrections for non-linear transformations such as
compression and shear may be explored to further improve the internal
co-registration. Due to increased number of degrees of freedom of the
model, a careful validation of the results will have to be ensured to
avoid over-ﬁtting.
Despite the clear improvements in image co-registration achieved,
there remain some limitations to our study. Firstly, the described two-
step hardware and software framework is designed to aid with 2D co-
registration, which assumes already the correct, manual choice of
matching imaging slice between the modalities. The use of the silicone
holder can help in this task, as the similar cross-sectional shape of the
tumour in the MRI can help match it qualitatively to the geometry in
the MSOT. Slice misalignment, although minimised with the use of the
holder and an optimised slice registration protocol, can introduce ad-
ditional error in the co-registration procedure.
A second limitation arises in the design of the silicone bed, which
aimed to mimic the eﬀects of the polyethylene ﬁlm holder used in the
MSOT, as well as the stresses due to water submersion during MSOT
imaging. In order to support the weight of the animal, the silicone had
to be stiﬀer than optimal, causing some discrepancy in MRI/MSOT
mouse positioning. Further optimisation using silicones of diﬀerent
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Fig. 6. Anatomical features in three K8484 tumours after landmark-based body and tumour contour registration. The red asterisks mark the selected feature centroids
by the ﬁrst operator. Across all observers and tumours, a range of 0.95–6.7 pixels for euclidean distances between MRI and MSOT was calculated. This corresponds to
a range from 71 μm to 503 μm in registration error.
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elastic properties could better match the distribution of forces and
should be investigated in future experiments.
Finally, the silicone bed was created for a speciﬁc mouse size based
on the typical usage in our experiments. If needed, additional silicone
beds could be created to account for diﬀerent mouse sizes, across strain
and age for instance, and taking the individual tumour position into
consideration. The optimal approach would utilize 3D modeling to
create mouse-speciﬁc holders and require standardisation of the mod-
elling, printing and casting workﬂow.
4.1. Conclusion
We have demonstrated the feasibility of a hardware- and software-
based image registration framework for MRI and MSOT images. We use
a novel silicone MRI holder, as well as a software tool to perform
landmark-based co-registration of the images. Both steps led to a sig-
niﬁcant improvement in the registration of the tumour outlines and
internal structure between the modalities. This simple, inexpensive
approach can be readily implemented for multi-modal MSOT/MRI
studies of mice, which will help to provide valuable insight into relative
performance of these two modalities in revealing vascular architecture
and function in cancer.
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